SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-016984
Filing Date
2019-08-30
Accepted
2019-08-30 11:49:55
Documents
113
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2019_alteritytherape.htm 20-F 2689574
2 LIST OF SUBSIDIARIES OF THE REGISTRANT f20f2019ex8-1_alterity.htm EX-8.1 2059
3 CERTIFICATION f20f2019ex12-1_alterity.htm EX-12.1 10630
4 CERTIFICATION f20f2019ex12-2_alterity.htm EX-12.2 10570
5 CERTIFICATION f20f2019ex13-1_alterity.htm EX-13.1 4716
6 CERTIFICATION f20f2019ex13-2_alterity.htm EX-13.2 4600
7 CONSENT OF PRICEWATERHOUSECOOPERS f20f2019ex15-1_alterity.htm EX-15.1 1747
14 GRAPHIC img_001.jpg GRAPHIC 5413
  Complete submission text file 0001213900-19-016984.txt   12665140

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE FILE ath-20190630.xml EX-101.INS 3772115
9 XBRL SCHEMA FILE ath-20190630.xsd EX-101.SCH 106343
10 XBRL CALCULATION FILE ath-20190630_cal.xml EX-101.CAL 65516
11 XBRL DEFINITION FILE ath-20190630_def.xml EX-101.DEF 280949
12 XBRL LABEL FILE ath-20190630_lab.xml EX-101.LAB 545613
13 XBRL PRESENTATION FILE ath-20190630_pre.xml EX-101.PRE 432740
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 20-F | Act: 34 | File No.: 000-49843 | Film No.: 191068590
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences